MDI-403
MDI-403 is a retinoic acid receptor (RAR) agonist with an EC50 value of less than 1 μM. MDI-403 exhibits significant antiviral activity against SARS-CoV-2, and can dose-dependently inhibit the expression of viral nucleoprotein (NP) and reduce the proportion of infected cells. MDI-403 mainly acts during the virus invasion stage. MDI-403 can be used in research on anti-SARS-CoV-2.
Nos produits utilisent uniquement pour la recherche. Nous ne vendons pas aux patients.
- CAS No.: 127471-94-7
- Formule: C29H36O4
- Masse moléculaire:448.59
-
Stockage:
Please store the product under the recommended conditions in the Certificate of Analysis.
Activité biologique
Description
Chemical Information
-
CAS No. 127471-94-7
-
Masse moléculaire 448.59
-
Formule C29H36O4
-
SMILES
C(=C/C(=C/C=C/C(=C\C(OCC(=O)C1=CC=C(OC)C=C1)=O)/C)/C)\C=2C(C)(C)CCCC2C
-
Livraison
Room temperature in continental US; may vary elsewhere.
-
Stockage
Please store the product under the recommended conditions in the Certificate of Analysis.
Pureté et documentation
Références
Calculators
Concentration (start) × Volume (start) = Concentration (final) × Volume (final)
Keywords
- MDI-403
- 127471-94-7
- MDI403
- MDI 403
- RAR/RXR
- SARS-CoV
- Retinoic acid receptors
- Retinoid X receptors
- SARS coronavirus
- SARS-CoV-2
- drug repurposing
- ReFRAME library
- antiviral compounds
- RAR agonist
- high-throughput screening
- viral replication inhibition
- Vero E6 cells
- dose-response
- synergy with remdesivir
- Inhibitor
- inhibitor
- inhibit